Patents by Inventor Christian C. Haudenschild

Christian C. Haudenschild has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6040057
    Abstract: Materials variously treated with sodium silicate were studied until enough information was obtained to find a way to solve the problems that have prevented sodium silicate from being the used as a fire retardant. These problems are: 1) water solubility (miscible with water), which results in extensive leaching when exposed to water, 2) cracking, chipping and peeling of treated surfaces, and 3) surface granulation. During flame tests it was discovered that sodium silicate formed a foam-like material, and this material was found to have become water insoluble, yet its elemental composition had remained virtually identical to that of the unmodified sodium silicate. This investigator proposes that under the influence of heat and dehydration, sodium silicate undergoes a polymerization process resulting in particles sizes too large to dissolve in water, and then developed a mechanism to explain how the process could occur.
    Type: Grant
    Filed: April 11, 1997
    Date of Patent: March 21, 2000
    Assignee: Karen M. Slimak
    Inventors: Robert A. Slimak, Christian C. Haudenschild, Karen M. Slimak
  • Patent number: 5464395
    Abstract: A catheter for delivering therapeutic and/or diagnostic agents directly into the tissue surrounding a bodily passageway. The catheter comprises at least one needle cannula able to be projected outboard of the catheter so as to deliver the desired agents to the tissue. The catheter also preferrably includes one or more inflatable balloons.
    Type: Grant
    Filed: April 5, 1994
    Date of Patent: November 7, 1995
    Inventors: David P. Faxon, Christian C. Haudenschild
  • Patent number: 4778787
    Abstract: Angiogenesis healing factors residing in omentum-derived lipid fractions with or without gangliosides or their synthetic equivalents can be used to treat myocardial ischemic conditions including but not limited to myocardial infarction, angina, as well as in heart transplant, vascular grafts, and re-opened vessels leading to improved vascularization, perfusion, collagenization and organization of said lesions; the involved and adjacent tissues.
    Type: Grant
    Filed: December 20, 1985
    Date of Patent: October 18, 1988
    Assignees: Trustees of Boston University, Angio-Medical Corporation
    Inventors: Nicholas Catsimpoolas, Haralambos Gavras, Christian C. Haudenschild, Michael I. Klibaner
  • Patent number: RE40517
    Abstract: Materials variously treated with sodium silicate were studied until enough information was obtained to find a way to solve the problems that have prevented sodium silicate from being the used as a fire retardant. These problems are: 1) water solubility (miscible with water), which results in extensive leaching when exposed to water, 2) cracking, chipping and peeling of treated surfaces, and 3) surface granulation. During flame tests it was discovered that sodium silicate formed a foam-like material, and this material was found to have become water insoluble, yet its elemental composition had remained virtually identical to that of the unmodified sodium silicate. This investigator proposes that under the influence of heat and dehydration, sodium silicate undergoes a polymerization process resulting in particles sizes too large to dissolve in water, and then developed a mechanism to explain how the process could occur.
    Type: Grant
    Filed: March 18, 2004
    Date of Patent: September 23, 2008
    Inventors: Robert A. Slimak, Christian C. Haudenschild, Karen M. Slimak